drugset / Trial / NCT01298960

Growth Hormone (GH) in in Vitro Fertilization (IVF) Poor-responder Patients

NCT01298960

Phase 2 Terminated 52 enrolled Fundacion Dexeus
RandomizedParallel-groupOpen-labelTreatment

Summary

Experimental study to evaluate if rGH addition to a standard controlled ovarian stimulation treatment improves ovarian response in women with previous poor ovarian response.

Timeline

Start
2011-02
Primary completion
2013-06
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Somatropin Protein / enzyme biologic 0.1 iu/kg

Indications

No indication recorded.